Paterna Biosciences

Paterna Biosciences is gathering interest from men for upcoming fertility research studies.

Paterna Biosciences publishes research on male fertility, reproductive health, stem cell science, and cancer.

Six conditions can cause testicular shrinkage. Many men stay silent. Dr. Alex Pastuszak discusses the causes, the warning signs, and when to act fast.

Healthcare IT News featured Paterna Biosciences CEO Dr. Alex Pastuszak on lab-grown human sperm and the future of male fertility treatment.

Paterna Biosciences achieved a world first by growing human sperm entirely outside the body, advancing new possibilities in male fertility.

The Salt Lake Tribune features Utah-based Paterna Biosciences and its first-in-history work growing human sperm in vitro.

Former senior FDA official with deep CBER experience sought to advise regulatory strategy and submissions for a first-in-class biologic with no direct precedent.

Apply for the Laboratory Associate position at Paterna Biosciences in Salt Lake City and work in cell culture, stem cells and reproductive science.

Senior regulatory strategist role leading CBER strategy for a first-in-class biologic. U.S.-based; employee or consulting engagement.

Paterna Biosciences is an Equal Employment Opportunity employer focused on workplace diversity and inclusion.

The page provides bios of team members, including their roles, experience, and unique contributions.

Paterna Biosciences reports achieving the first in vitro human spermatogenesis, detailed in WIRED.

Paterna Biosciences develops solutions for male fertility, targeting advancements in family building.

Paterna Biosciences offers investment opportunities in male fertility solutions and biotech advancements.

Paterna Biosciences addresses male infertility through in vitro spermatogenesis and shares its scientific work.

Paterna Biosciences successfully grows functional human sperm in a lab, marking the first such achievement. The company demonstrates viability by fertilizing human eggs with the lab-grown sperm, resulting in embryo formation. This breakthrough advances male reproductive medicine by offering a potential new solution for infertility.

May 2026BioSpaceNews article

Paterna Biosciences grows human sperm from stem cells in a lab for the first time. The company publicly reveals its in vitro sperm development process, marking a milestone in reproductive biology research. This breakthrough could advance infertility treatments and reproductive science.

Apr 2026Paterna BiosciencesNews article

Paterna secures the Disruption Award at the Mayo Clinic and Arizona State University (ASU) MedTech Accelerator for its male fertility technology. The innovation targets an unmet need in reproductive healthcare, offering a novel solution in the field. The award recognizes its potential to disrupt traditional approaches to fertility treatments.

Mar 2025Paterna BiosciencesNews article

Paterna secures a spot in the **Mayo Clinic and ASU MedTech Accelerator’s 2025 life sciences cohort**, accelerating development of its **male fertility treatment**. The accelerator supports early-stage medical technologies through clinical and commercialization expertise.

Mar 2025Paterna BiosciencesNews article